Literature DB >> 8757889

Tumor necrosis factor primes neutrophils to kill Staphylococcus aureus by an oxygen-dependent mechanism and Plasmodium falciparum by an oxygen-independent mechanism.

I C Kowanko1, A Ferrante, G Clemente, L M Kumaratilake.   

Abstract

The cytokine tumor necrosis factor (TNF) plays the important role of priming neutrophils for increased antimicrobial activity. We now demonstrate that human neutrophils which lack the ability to generate oxygen radicals, from patients with chronic granulomatous disease, show TNF-induced enhancement of killing of intraerythrocytic stages of Plasmodium falciparum but not of Staphylococcus aureus.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8757889      PMCID： PMC174244          DOI： 10.1128/iai.64.8.3435-3437.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  14 in total

1.  Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor.

Authors:  J Y Djeu; D K Blanchard; D Halkias; H Friedman
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

2.  Antibacterial activity of cationic proteins from human granulocytes.

Authors:  H Odeberg; I Olsson
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

3.  Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation.

Authors:  A Ferrante; M Nandoskar; A Walz; D H Goh; I C Kowanko
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

5.  Separation of mononuclear and polymorphonuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column height.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

6.  Stimulation of neutrophils by tumor necrosis factor.

Authors:  S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

7.  Polymorphonuclear leucocytes defective in oxidative metabolism inhibit in vitro growth of Plasmodium falciparum. Evidence against an oxygen-dependent mechanism.

Authors:  A Kharazmi; S Jepsen; N H Valerius
Journal:  Scand J Immunol       Date:  1984-07       Impact factor: 3.487

8.  Interaction of Staphylococcus aureus with human neutrophils and the down-regulation of TNF receptors.

Authors:  A Ferrante; A J Martin; E J Bates; I C Kowanko; D P Harvey; D Parsons; D A Rathjen; G Russ; J M Dayer
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

9.  Hydroxyl radical scavengers produce similar decreases in the chemiluminescence responses and bactericidal activities of neutrophils.

Authors:  J E Repine; K S Johansen; E M Berger
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release.

Authors:  A Ferrante
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441
View more
  7 in total

1.  Staphylococcus aureus SaeR/S-Regulated Factors Decrease Monocyte-Derived Tumor Necrosis Factor-α to Reduce Neutrophil Bactericidal Activity.

Authors:  Eli W Sward; Elizabeth M Fones; Russel R Spaan; Kyler B Pallister; Brandon L Haller; Fermin E Guerra; Oliwia W Zurek; Tyler K Nygaard; Jovanka M Voyich
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

2.  Stimulation of gp91 phagocytic oxidase and reactive oxygen species in neutrophils by an avirulent Salmonella enterica serovar infantis strain protects gnotobiotic piglets from lethal challenge with serovar Typhimurium strain F98 without inducing intestinal pathology.

Authors:  Neil Foster; Scott Hulme; Margaret Lovell; Katharine Reed; Paul Barrow
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.

Authors:  Zvjezdana Sever-Chroneos; Agnieszka Krupa; Jeremy Davis; Misbah Hasan; Ching-Hui Yang; Jacek Szeliga; Mathias Herrmann; Muzafar Hussain; Brian V Geisbrecht; Lester Kobzik; Zissis C Chroneos
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

4.  Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.

Authors:  J A Martiney; B Sherry; C N Metz; M Espinoza; A S Ferrer; T Calandra; H E Broxmeyer; R Bucala
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Role of the extracellular signal-regulated protein kinase cascade in human neutrophil killing of Staphylococcus aureus and Candida albicans and in migration.

Authors:  C S Hii; K Stacey; N Moghaddami; A W Murray; A Ferrante
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

6.  Complement Receptor 3 Contributes to the Sexual Dimorphism in Neutrophil Killing of Staphylococcus aureus.

Authors:  Srijana Pokhrel; Kathleen D Triplett; Seth M Daly; Jason A Joyner; Geetanjali Sharma; Helen J Hathaway; Eric R Prossnitz; Pamela R Hall
Journal:  J Immunol       Date:  2020-08-07       Impact factor: 5.422

7.  Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction.

Authors:  Aubrey J Cunnington; Madi Njie; Simon Correa; Ebako N Takem; Eleanor M Riley; Michael Walther
Journal:  J Immunol       Date:  2012-10-24       Impact factor: 5.422
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.